Latest Alcohols Stories

Fuisz Comments On Opioid Abuse Detection Systems, Tamper Resistance And The Proposed STOPP Act (HR 6160)

2012-12-20 12:27:18

MIAMI, Dec. 20, 2012 /PRNewswire/ -- Fuisz Pharma LLC today addressed tamper resistance in the context of the Stop Tampering of Prescription Pills Act (STOPP) (H. R. 6160). This law would require the makers of generic opioids to demonstrate comparable tamper-resistance features to the reference, branded opioid tamper-resistant formulations. Richard C. Fuisz, M.D., founding member of Fuisz Pharma (http://en.wikipedia.org/wiki/Richard_Fuisz) commented: "I have been a physician...

Atlantic Pharmaceuticals, Inc. Announces Two Patent Issuances for Its Tamper-Resistant Pharmaceutical Platform

2012-12-20 08:27:20

ATLANTA, Dec. 20, 2012 /PRNewswire/ -- Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that new patents have been issued by the U.S. Patent and Trademark Office (USPTO) relating to its tamper-resistant SMART/Script(TM) drug delivery platform. U.S. Patent Nos. 8,187,636 and 8,349,362 contain claims that cover Atlantic's proprietary tamper-resistant platform which are designed to resist dose dumping of orally delivered opioids and may sequester and...

Endo Health Solutions Comments on Dismissal of Suit Against FDA

2012-12-19 16:24:14

CHADDS FORD, Pa., Dec. 19, 2012 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that U.S. District Judge Reggie B. Walton, of the U.S. District Court for the District of Columbia, dismissed the case of Endo's subsidiary, Endo Pharmaceuticals Inc., against the U.S. Food and Drug Administration (FDA). Endo Pharmaceuticals argued that FDA failed to meet its legal obligation to determine in a timely manner whether the original formulation of OPANA ER was...

Mylan Launches Generic Version of Qualaquin® Capsules

2012-12-18 12:27:12

PITTSBURGH, Dec. 18, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Quinine Sulfate Capsules USP, 324 mg. This product is the generic version of Mutual Pharmaceutical Company, Inc.'s Qualaquin(®) Capsules, and is an antimalarial drug indicated only for treatment of uncomplicated Plasmodium...

Drug To Treat Opioid Addiction Poses Risks For Accidental Exposure To Children

2012-12-17 11:14:57

Buprenorphine is a safe and effective drug for treating opioid addiction. But as the prescribed use of buprenorphine has dramatically increased in recent years, accidental exposure of children to the drug has risen sharply, placing them at risk for serious injury and in extremely rare cases even death, according to researchers at the Utah Poison Control Center (UPCC), U School of Medicine's Department of Family and Preventive Health, and the Utah Department of Health (UDOH). In a study...

Endo Health Solutions Launches 7.5mg and 15mg strengths of Reformulated, Designed to be Crush-Resistant, OPANA® ER

2012-12-11 12:27:59

CHADDS FORD, Pa., Dec. 11, 2012 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that its subsidiary, Endo Pharmaceuticals Inc., has launched 7.5mg and 15mg strengths of its reformulated, designed to be crush-resistant, OPANA(®) ER (oxymorphone HCl) product. Now commercially available, the 7.5mg and 15mg options complete the launch of all approved strengths of the reformulated version of OPANA ER with INTAC(®) technology. The product is now available in...

Kona Coffee Promotion From Nutrex Hawaii

2012-12-08 05:04:00

Nutrex Hawaii, producer of microalgae-based Hawaiian Spirulina Pacifica® and BioAstin® Hawaiian Astaxanthin™ supernutrients has launched a new promotion open to Hawaiian enthusiasts nationwide. The first 200 orders of $100 or more at http://www.nutrex-hawaii.com to use the special promo code KONACOFFEE will receive a four-ounce bag of world-renown Kona coffee along with their order. KAILUA-KONA, Hawaii (PRWEB) December 07, 2012 Nutrex Hawaii, producer of microalgae-based...

Suppress Appetite Naturally and Reach Weight Loss Goals with Powerful Spice and Dietary Supplement, Saffron Extract

2012-12-01 05:01:58

Everyone wants a quick-fix that can help them lose weight and fit into those skinny jeans and Saffron Extract, a clinically proven appetite suppressant and weight loss product may help dieters lose weight quickly and safely. EverydayVitamin.com offers Pure and Potent Saffron Extract from Genesis Today™, among its growing inventory of appetite control and weight loss products. Brooklyn, NY (PRWEB) November 30, 2012 Saffron Extract was recently recommended by Dr. Oz as a great appetite...

Endo Health Solutions Sues FDA to Protect Consumers from Non-Tamper Resistant Oxymorphone

2012-11-30 16:22:40

CHADDS FORD, Pa., Nov. 30, 2012 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that its subsidiary, Endo Pharmaceuticals Inc., has filed suit against the U.S. Food and Drug Administration (FDA) seeking a formal determination whether the original formulation of OPANA(® )ER (oxymorphone HCl) was voluntarily removed from the market in 2012 for reasons of safety involving the misuse of the drug; and FDA's immediate suspension of any abbreviated new drug...

Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update

2012-11-27 08:28:54

ALISO VIEJO, Calif., Nov. 27, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced preliminary results for the quarter ended September 30, 2012. Financial Update Based on preliminary results for the fourth fiscal quarter ended September 30, 2012, Avanir estimates: Gross revenue for NUEDEXTA® of $15.4 million, representing an increase of approximately 26% over the prior quarter Total operating expenses, excluding cost of product sales and non-cash...